Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1995
06/01/1995WO1995014493A1 Three-step pretargeting methods and compounds
06/01/1995WO1995014483A1 Composition comprising sulcralfate and an antimicrobial agent/ion-exchange resin complex
06/01/1995WO1995014481A1 Use of lithium compounds in the treatment and prevention of alzheimer's disease
06/01/1995WO1995014479A1 Condensation polymer of an aromatic sulfonic acid and an aldehyde for inhibiting hiv infectivity
06/01/1995WO1995014478A1 Purine compositions and methods for administration
06/01/1995WO1995014477A1 The use of an ester of inositoltrisphosphate for the treatment of inflammatory conditions
06/01/1995WO1995014476A1 The use of an ester of inositoltrisphosphate for the preparing of an analgetic medicament
06/01/1995WO1995014475A1 The use of an ester of inositoltrisphosphate for the preparing of medicaments
06/01/1995WO1995014474A1 Budesonide medicament to improve enteral fluid resorption, especially following post-operative conditions
06/01/1995WO1995014473A1 Antiarrhythmic benzodiazepines
06/01/1995WO1995014472A1 Antiarrhythmic benzodiazepines
06/01/1995WO1995014471A1 Antiarrhythmic benzodiazepines
06/01/1995WO1995014470A1 Methods of treating cardiac arrhythmia
06/01/1995WO1995014468A1 Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis
06/01/1995WO1995014467A1 Therapeutic guanidines
06/01/1995WO1995014465A2 Methods for amelioration of immunodeficiency virus induced neurodegeneration by covering nitric oxide or superoxide concentration
06/01/1995WO1995014464A1 Ssi tyrphostins and pharmaceutical compositions
06/01/1995WO1995014463A1 Composition of pharmaceutical preparation improved in peroral absorbability
06/01/1995WO1995014462A1 Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide
06/01/1995WO1995014461A1 Therapeutic substituted guanidines
06/01/1995WO1995014460A1 Opioid formulations for treating pain
06/01/1995WO1995014459A1 Liposomes for the encapsulation of doxorubicine
06/01/1995WO1995014457A1 Compositions comprising iminium ion scavengers and/or nitrite scavengers
06/01/1995WO1995014436A1 A retrograde high frequency tissue splitter
06/01/1995WO1995014385A1 Triazole phosphonate pesticides
06/01/1995WO1995014384A1 Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds
06/01/1995WO1995005384A1 Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity
06/01/1995WO1995004525A3 Use of tumor necrosis factor inhibitors together with antiviral agents and therapeutic compositions thereof against hiv infection
06/01/1995DE4340767A1 Ketamine admin.
06/01/1995DE4340484A1 Compsn. contg. mucosally absorbed alkali or ammonium humate
06/01/1995DE4340438A1 Use of bio-flavonoid, esp. rutin for retrovirus inactivation
06/01/1995DE4340273A1 Medicament contg. lithium cpd.
06/01/1995DE4340045A1 New (heterocyclyl)pyrrolyl-substd. quinoxaline-di:one derivs.
06/01/1995DE4339985A1 Pharmaceutical compsn. contg. di:halo-quinoline deriv.
06/01/1995CA2224051A1 Intermediates for producing substituted indoles as phosphodiesterase type iv inhibitors
06/01/1995CA2224049A1 Intermediates for producing substituted indoles as phosphodiesterase type iv inhibitors
06/01/1995CA2177388A1 Design of drugs involving receptor-ligand-dna interactions
06/01/1995CA2177375A1 3-aryl-2-isoxazolines as antiinflammatory agents
06/01/1995CA2177289A1 Ssi tyrphostins and pharmaceutical compositions
06/01/1995CA2177256A1 Triazole phosphonate pesticides
06/01/1995CA2177084A1 Therapeutic guanidines
06/01/1995CA2177081A1 Therapeutic substituted guanidines
06/01/1995CA2177074A1 P53-binding polypeptides and polynucleotides encoding same
06/01/1995CA2177037A1 Three-step pretargeting methods and compounds
06/01/1995CA2176961A1 Heterocyclic esters of rapamycin and pharmaceutical compositions containing them
06/01/1995CA2176955A1 Hindered esters of rapamycin and their use as pharmaceuticals
06/01/1995CA2176743A1 Compositions comprising iminium ion scavengers and/or nitrite scavengers
06/01/1995CA2176377A1 Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds
06/01/1995CA2176251A1 Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis
06/01/1995CA2176140A1 Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
06/01/1995CA2176022A1 Antiarrhythmic benzodiazepines
06/01/1995CA2176021A1 Methods of treating cardiac arrhythmia
06/01/1995CA2176020A1 Benzodiazepines
06/01/1995CA2176019A1 3-acylaminobenzazepines
06/01/1995CA2176018A1 Novel furanodiazepines
06/01/1995CA2176017A1 Imidazolinobenzodiazepines
06/01/1995CA2176016A1 Antiarrhythmic benzodiazepines
06/01/1995CA2176015A1 Antiarrhythmic benzodiazepines
06/01/1995CA2175828A1 Purine compositions and methods for administration
06/01/1995CA2175217A1 3-acylaminobenzodiazepines
06/01/1995CA2174838A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
06/01/1995CA2174415A1 Isoxazoline compounds useful as fibrinogen receptor antagonists
06/01/1995CA2154475A1 4,5-diphenylimidazole derivatives, their preparation and their use as acyl coenzyme a: cholesterol-0-acyl-transferase (acat) inhibitor
06/01/1995CA2153690A1 Novel substituted thiosemicarbazonic acid esters
06/01/1995CA2153689A1 Novel substituted thiosemicarbazone derivatives
06/01/1995CA2153580A1 Novel substitued thiosemicarbazonethiones
05/1995
05/31/1995EP0655458A2 New method of preparation of finasteride
05/31/1995EP0655455A1 Novel phosporus containing pyridine derivatives
05/31/1995EP0655449A1 A process for preparing N-( 2-pyrimidyl) piperazinyl butyl imides
05/31/1995EP0655447A1 Epoxysuccinic acid derivatives
05/31/1995EP0655445A1 1,3,4-oxadiazol-2(3H)-one Derivates, their preparation and their use as monoamine oxidase inhibitors
05/31/1995EP0655442A1 Piperazine derivatives as Tachykinin antagonists
05/31/1995EP0655441A1 Crystal modification of (4-cyclopropyl-6-methyl-pyrimidin-2-yl)-phenyl-amine, process for its préparation and its use as fungicide
05/31/1995EP0655440A2 1-Aminoethylindoles
05/31/1995EP0655439A2 5,6-Bicyclic glycoprotein IIb IIIa antagonists useful in inhibition of platelet aggregation
05/31/1995EP0655249A1 Moenomycin as a medicament for the treatment of stomach ulcer
05/31/1995EP0655248A1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion
05/31/1995EP0655247A1 Use of vincristine for the evaluation of substances at the neuroral level
05/31/1995EP0655246A1 Substance P antagonists for the treatment of disorders caused by helicobacter pylori or other spiral urease-positive gram-negative bacteria
05/31/1995EP0655245A2 Compositions and their use for retarding the aging process
05/31/1995EP0655244A1 Amino acid composition for the treatment of infections
05/31/1995EP0655243A2 Melatonin derivatives for use in treating sleep disorders
05/31/1995EP0655242A1 Use of coumarin derivatives in the treatment of NO induced disorders
05/31/1995EP0655240A2 Immediate release tablet cores of insoluble drugs having substained-release coating
05/31/1995EP0655239A1 Liposomes encapsulating doxorubicine
05/31/1995EP0655235A1 Slimming composition
05/31/1995EP0655088A1 Oligonucleotides having chiral phosphorus linkages
05/31/1995EP0655070A1 Triantennary cluster glycosides, their preparation and use
05/31/1995EP0655066A1 Protein kinase inhibitors and related compounds combined with taxol
05/31/1995EP0655063A1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension
05/31/1995EP0655060A1 Pharmaceutically active diketopiperazines
05/31/1995EP0655058A1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/31/1995EP0655056A1 Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension
05/31/1995EP0655055A1 Tachykinin antagonists
05/31/1995EP0654999A1 Use of inhibitors of vacuolar-type h?+ atpases
05/31/1995EP0654998A1 METHOD OF NEUTRALIZING IL-1 USING dsRNAs
05/31/1995EP0654997A1 Compositions of substituted azaspiranes and methods of treating psoriasis therewith
05/31/1995EP0654996A1 Methods of treating psoriasis employing substituted azaspiranes
05/31/1995EP0654994A1 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
05/31/1995EP0654993A1 Method for destroying or inhibiting growth of unwanted cells or tissues
1 ... 7014 7015 7016 7017 7018 7019 7020 7021 7022 7023 7024 7025 7026 7027 7028 7029 7030 7031 7032 7033 7034 ... 7860